nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludrocortisone—AR—Ergocalciferol—osteoporosis	0.319	0.658	CbGbCtD
Fludrocortisone—AR—Estradiol—osteoporosis	0.166	0.342	CbGbCtD
Fludrocortisone—Methyltestosterone—Ethinyl Estradiol—osteoporosis	0.152	0.523	CrCrCtD
Fludrocortisone—Testosterone—Estradiol—osteoporosis	0.139	0.477	CrCrCtD
Fludrocortisone—NR3C2—ACE Inhibitor Pathway—REN—osteoporosis	0.00499	0.117	CbGpPWpGaD
Fludrocortisone—NR3C2—ACE Inhibitor Pathway—ACE—osteoporosis	0.00311	0.073	CbGpPWpGaD
Fludrocortisone—AR—Nongenotropic Androgen signaling—SHBG—osteoporosis	0.00238	0.0558	CbGpPWpGaD
Fludrocortisone—Osteoporosis—Etidronic acid—osteoporosis	0.00222	0.0125	CcSEcCtD
Fludrocortisone—Osteonecrosis—Pamidronate—osteoporosis	0.00217	0.0122	CcSEcCtD
Fludrocortisone—Trauma—Ibandronate—osteoporosis	0.00217	0.0122	CcSEcCtD
Fludrocortisone—Multiple fractures—Etidronic acid—osteoporosis	0.00214	0.012	CcSEcCtD
Fludrocortisone—Fracture—Etidronic acid—osteoporosis	0.00214	0.012	CcSEcCtD
Fludrocortisone—Glucose tolerance impaired—Estradiol—osteoporosis	0.00211	0.0119	CcSEcCtD
Fludrocortisone—Hypernatraemia—Estropipate—osteoporosis	0.00205	0.0115	CcSEcCtD
Fludrocortisone—Osteonecrosis—Zoledronate—osteoporosis	0.00198	0.0112	CcSEcCtD
Fludrocortisone—Peptic ulcer—Etidronic acid—osteoporosis	0.00186	0.0105	CcSEcCtD
Fludrocortisone—Hirsutism—Estropipate—osteoporosis	0.00185	0.0104	CcSEcCtD
Fludrocortisone—Multiple fractures—Ibandronate—osteoporosis	0.00178	0.00999	CcSEcCtD
Fludrocortisone—Fracture—Ibandronate—osteoporosis	0.00178	0.00999	CcSEcCtD
Fludrocortisone—Optic neuritis—Estropipate—osteoporosis	0.00175	0.00984	CcSEcCtD
Fludrocortisone—Trauma—Pamidronate—osteoporosis	0.0017	0.00955	CcSEcCtD
Fludrocortisone—Hypernatraemia—Pamidronate—osteoporosis	0.00154	0.00865	CcSEcCtD
Fludrocortisone—Fracture—Risedronate—osteoporosis	0.00146	0.00823	CcSEcCtD
Fludrocortisone—Multiple fractures—Risedronate—osteoporosis	0.00146	0.00823	CcSEcCtD
Fludrocortisone—Hypernatraemia—Zoledronate—osteoporosis	0.0014	0.0079	CcSEcCtD
Fludrocortisone—Dermatitis atopic—Ibandronate—osteoporosis	0.00139	0.00784	CcSEcCtD
Fludrocortisone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—RAP1A—osteoporosis	0.00138	0.0323	CbGpPWpGaD
Fludrocortisone—NR3C1—Signaling events mediated by HDAC Class II—TUBA1B—osteoporosis	0.00137	0.032	CbGpPWpGaD
Fludrocortisone—Hypernatraemia—Conjugated Estrogens—osteoporosis	0.00135	0.00761	CcSEcCtD
Fludrocortisone—NR3C2—Nuclear Receptor transcription pathway—ESR2—osteoporosis	0.00126	0.0297	CbGpPWpGaD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—GSN—osteoporosis	0.00123	0.0289	CbGpPWpGaD
Fludrocortisone—Amenorrhoea—Estropipate—osteoporosis	0.00123	0.00689	CcSEcCtD
Fludrocortisone—Hirsutism—Conjugated Estrogens—osteoporosis	0.00122	0.00688	CcSEcCtD
Fludrocortisone—Optic neuritis—Conjugated Estrogens—osteoporosis	0.00116	0.0065	CcSEcCtD
Fludrocortisone—Dermatitis atopic—Risedronate—osteoporosis	0.00115	0.00646	CcSEcCtD
Fludrocortisone—Oesophagitis—Etidronic acid—osteoporosis	0.00114	0.00639	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Etidronic acid—osteoporosis	0.00113	0.00636	CcSEcCtD
Fludrocortisone—Cataract—Ibandronate—osteoporosis	0.00108	0.0061	CcSEcCtD
Fludrocortisone—Hypernatraemia—Estradiol—osteoporosis	0.00108	0.00609	CcSEcCtD
Fludrocortisone—Menstruation irregular—Estradiol—osteoporosis	0.00103	0.00578	CcSEcCtD
Fludrocortisone—Fluid retention—Estropipate—osteoporosis	0.00102	0.00575	CcSEcCtD
Fludrocortisone—NR3C2—Nuclear Receptor transcription pathway—VDR—osteoporosis	0.001	0.0235	CbGpPWpGaD
Fludrocortisone—Amenorrhoea—Ethinyl Estradiol—osteoporosis	0.000993	0.00558	CcSEcCtD
Fludrocortisone—Hirsutism—Estradiol—osteoporosis	0.000979	0.00551	CcSEcCtD
Fludrocortisone—Contusion—Risedronate—osteoporosis	0.000975	0.00548	CcSEcCtD
Fludrocortisone—Neoplasm—Estropipate—osteoporosis	0.000973	0.00547	CcSEcCtD
Fludrocortisone—Oesophagitis—Alendronate—osteoporosis	0.000969	0.00545	CcSEcCtD
Fludrocortisone—NR3C2—ACE Inhibitor Pathway—TGFB1—osteoporosis	0.000957	0.0225	CbGpPWpGaD
Fludrocortisone—Oesophagitis—Ibandronate—osteoporosis	0.000943	0.0053	CcSEcCtD
Fludrocortisone—Ecchymosis—Ibandronate—osteoporosis	0.000933	0.00525	CcSEcCtD
Fludrocortisone—Optic neuritis—Estradiol—osteoporosis	0.000925	0.0052	CcSEcCtD
Fludrocortisone—AR—Androgen receptor signaling pathway—PARK7—osteoporosis	0.000911	0.0214	CbGpPWpGaD
Fludrocortisone—Thrombophlebitis—Estropipate—osteoporosis	0.000903	0.00508	CcSEcCtD
Fludrocortisone—Cataract—Risedronate—osteoporosis	0.000894	0.00503	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Raloxifene—osteoporosis	0.00087	0.00489	CcSEcCtD
Fludrocortisone—Injury—Estropipate—osteoporosis	0.00085	0.00478	CcSEcCtD
Fludrocortisone—Fluid retention—Ethinyl Estradiol—osteoporosis	0.000828	0.00466	CcSEcCtD
Fludrocortisone—Injury—Ibandronate—osteoporosis	0.000815	0.00458	CcSEcCtD
Fludrocortisone—Purpura—Estropipate—osteoporosis	0.000811	0.00456	CcSEcCtD
Fludrocortisone—Amenorrhoea—Conjugated Estrogens—osteoporosis	0.000809	0.00455	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Estropipate—osteoporosis	0.000807	0.00454	CcSEcCtD
Fludrocortisone—Neoplasm—Ethinyl Estradiol—osteoporosis	0.000789	0.00444	CcSEcCtD
Fludrocortisone—AR—Notch-mediated HES/HEY network—BGLAP—osteoporosis	0.000782	0.0184	CbGpPWpGaD
Fludrocortisone—Oesophagitis—Risedronate—osteoporosis	0.000777	0.00437	CcSEcCtD
Fludrocortisone—Cataract—Zoledronate—osteoporosis	0.000776	0.00436	CcSEcCtD
Fludrocortisone—Ecchymosis—Risedronate—osteoporosis	0.000769	0.00432	CcSEcCtD
Fludrocortisone—Neoplasm—Risedronate—osteoporosis	0.000769	0.00432	CcSEcCtD
Fludrocortisone—NR3C2—Nuclear Receptor transcription pathway—ESR1—osteoporosis	0.000766	0.018	CbGpPWpGaD
Fludrocortisone—AR—Nuclear Receptors—ESR2—osteoporosis	0.000742	0.0174	CbGpPWpGaD
Fludrocortisone—Mood swings—Estropipate—osteoporosis	0.00074	0.00416	CcSEcCtD
Fludrocortisone—Abdominal distension—Estropipate—osteoporosis	0.00068	0.00382	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Pamidronate—osteoporosis	0.000678	0.00381	CcSEcCtD
Fludrocortisone—Oedema—Calcium Acetate—osteoporosis	0.000676	0.0038	CcSEcCtD
Fludrocortisone—Fluid retention—Conjugated Estrogens—osteoporosis	0.000675	0.0038	CcSEcCtD
Fludrocortisone—Oesophagitis—Zoledronate—osteoporosis	0.000675	0.0038	CcSEcCtD
Fludrocortisone—Injury—Risedronate—osteoporosis	0.000672	0.00378	CcSEcCtD
Fludrocortisone—Abdominal distension—Alendronate—osteoporosis	0.00067	0.00377	CcSEcCtD
Fludrocortisone—Neoplasm—Zoledronate—osteoporosis	0.000668	0.00376	CcSEcCtD
Fludrocortisone—Pancreatitis—Estropipate—osteoporosis	0.000662	0.00372	CcSEcCtD
Fludrocortisone—Contusion—Estradiol—osteoporosis	0.000652	0.00367	CcSEcCtD
Fludrocortisone—Amenorrhoea—Estradiol—osteoporosis	0.000648	0.00364	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Pamidronate—osteoporosis	0.000647	0.00364	CcSEcCtD
Fludrocortisone—Neoplasm—Conjugated Estrogens—osteoporosis	0.000643	0.00362	CcSEcCtD
Fludrocortisone—Injury—Pamidronate—osteoporosis	0.000639	0.00359	CcSEcCtD
Fludrocortisone—Hypertension—Ergocalciferol—osteoporosis	0.000632	0.00355	CcSEcCtD
Fludrocortisone—Affect lability—Ethinyl Estradiol—osteoporosis	0.000623	0.00351	CcSEcCtD
Fludrocortisone—Pancreatitis—Calcitriol—osteoporosis	0.000622	0.0035	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Estropipate—osteoporosis	0.000609	0.00343	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Pamidronate—osteoporosis	0.000606	0.00341	CcSEcCtD
Fludrocortisone—Mood swings—Ethinyl Estradiol—osteoporosis	0.0006	0.00337	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Conjugated Estrogens—osteoporosis	0.000596	0.00335	CcSEcCtD
Fludrocortisone—AR—Nuclear Receptors—VDR—osteoporosis	0.000589	0.0138	CbGpPWpGaD
Fludrocortisone—AR—Nuclear Receptor transcription pathway—ESR2—osteoporosis	0.000586	0.0138	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—COL1A2—osteoporosis	0.000584	0.0137	CbGpPWpGaD
Fludrocortisone—Cardiac failure congestive—Conjugated Estrogens—osteoporosis	0.000569	0.0032	CcSEcCtD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—IRS2—osteoporosis	0.000566	0.0133	CbGpPWpGaD
Fludrocortisone—NR3C1—Nuclear Receptors—ESR2—osteoporosis	0.000563	0.0132	CbGpPWpGaD
Fludrocortisone—Injury—Conjugated Estrogens—osteoporosis	0.000562	0.00316	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—DKK1—osteoporosis	0.000556	0.0131	CbGpPWpGaD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—LEP—osteoporosis	0.000554	0.013	CbGpPWpGaD
Fludrocortisone—Abdominal distension—Ethinyl Estradiol—osteoporosis	0.000551	0.0031	CcSEcCtD
Fludrocortisone—Muscular weakness—Risedronate—osteoporosis	0.000545	0.00306	CcSEcCtD
Fludrocortisone—Erythema—Etidronic acid—osteoporosis	0.000544	0.00306	CcSEcCtD
Fludrocortisone—Fluid retention—Estradiol—osteoporosis	0.00054	0.00304	CcSEcCtD
Fludrocortisone—Abdominal distension—Risedronate—osteoporosis	0.000537	0.00302	CcSEcCtD
Fludrocortisone—Purpura—Conjugated Estrogens—osteoporosis	0.000536	0.00301	CcSEcCtD
Fludrocortisone—Haemoglobin—Alendronate—osteoporosis	0.000535	0.00301	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Conjugated Estrogens—osteoporosis	0.000533	0.003	CcSEcCtD
Fludrocortisone—Haemorrhage—Alendronate—osteoporosis	0.000532	0.00299	CcSEcCtD
Fludrocortisone—Haemoglobin—Ibandronate—osteoporosis	0.000521	0.00293	CcSEcCtD
Fludrocortisone—Haemorrhage—Ibandronate—osteoporosis	0.000518	0.00291	CcSEcCtD
Fludrocortisone—Neoplasm—Estradiol—osteoporosis	0.000515	0.00289	CcSEcCtD
Fludrocortisone—Haemoglobin—Calcitriol—osteoporosis	0.00051	0.00287	CcSEcCtD
Fludrocortisone—Haemorrhage—Calcitriol—osteoporosis	0.000507	0.00285	CcSEcCtD
Fludrocortisone—Fluoxymesterone—SHBG—osteoporosis	0.000501	0.116	CrCbGaD
Fludrocortisone—Hypersensitivity—Calcium Acetate—osteoporosis	0.000498	0.0028	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—COL1A2—osteoporosis	0.000498	0.0117	CbGpPWpGaD
Fludrocortisone—Sweating increased—Pamidronate—osteoporosis	0.000494	0.00278	CcSEcCtD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—IRS1—osteoporosis	0.000494	0.0116	CbGpPWpGaD
Fludrocortisone—Mood swings—Conjugated Estrogens—osteoporosis	0.000489	0.00275	CcSEcCtD
Fludrocortisone—Asthenia—Calcium Acetate—osteoporosis	0.000485	0.00273	CcSEcCtD
Fludrocortisone—NR3C1—Endoderm Differentiation—DKK1—osteoporosis	0.00048	0.0113	CbGpPWpGaD
Fludrocortisone—Thrombophlebitis—Estradiol—osteoporosis	0.000477	0.00268	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—NFATC1—osteoporosis	0.000473	0.0111	CbGpPWpGaD
Fludrocortisone—Muscular weakness—Zoledronate—osteoporosis	0.000473	0.00266	CcSEcCtD
Fludrocortisone—Erythema—Estropipate—osteoporosis	0.000471	0.00265	CcSEcCtD
Fludrocortisone—Abdominal distension—Zoledronate—osteoporosis	0.000467	0.00262	CcSEcCtD
Fludrocortisone—AR—Nuclear Receptor transcription pathway—VDR—osteoporosis	0.000465	0.0109	CbGpPWpGaD
Fludrocortisone—Erythema—Alendronate—osteoporosis	0.000463	0.00261	CcSEcCtD
Fludrocortisone—Vascular purpura—Estradiol—osteoporosis	0.000462	0.0026	CcSEcCtD
Fludrocortisone—Spironolactone—SHBG—osteoporosis	0.000459	0.107	CrCbGaD
Fludrocortisone—Sweating increased—Zoledronate—osteoporosis	0.000451	0.00254	CcSEcCtD
Fludrocortisone—Erythema—Ibandronate—osteoporosis	0.000451	0.00254	CcSEcCtD
Fludrocortisone—AR—Nuclear Receptors—ESR1—osteoporosis	0.00045	0.0106	CbGpPWpGaD
Fludrocortisone—Injury—Estradiol—osteoporosis	0.00045	0.00253	CcSEcCtD
Fludrocortisone—Abdominal distension—Conjugated Estrogens—osteoporosis	0.000449	0.00253	CcSEcCtD
Fludrocortisone—NR3C1—Nuclear Receptors—VDR—osteoporosis	0.000447	0.0105	CbGpPWpGaD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—ESR2—osteoporosis	0.000445	0.0104	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—COL1A2—osteoporosis	0.000443	0.0104	CbGpPWpGaD
Fludrocortisone—Erythema—Calcitriol—osteoporosis	0.000442	0.00248	CcSEcCtD
Fludrocortisone—Infection—Etidronic acid—osteoporosis	0.000441	0.00248	CcSEcCtD
Fludrocortisone—Haemoglobin—Ethinyl Estradiol—osteoporosis	0.00044	0.00248	CcSEcCtD
Fludrocortisone—Haemorrhage—Ethinyl Estradiol—osteoporosis	0.000438	0.00246	CcSEcCtD
Fludrocortisone—Pancreatitis—Conjugated Estrogens—osteoporosis	0.000437	0.00246	CcSEcCtD
Fludrocortisone—Sweating increased—Conjugated Estrogens—osteoporosis	0.000435	0.00244	CcSEcCtD
Fludrocortisone—Medroxyprogesterone Acetate—SHBG—osteoporosis	0.00043	0.0999	CrCbGaD
Fludrocortisone—Haemoglobin—Risedronate—osteoporosis	0.000429	0.00241	CcSEcCtD
Fludrocortisone—Purpura—Estradiol—osteoporosis	0.000429	0.00241	CcSEcCtD
Fludrocortisone—Asthenia—Ergocalciferol—osteoporosis	0.000429	0.00241	CcSEcCtD
Fludrocortisone—Haemorrhage—Risedronate—osteoporosis	0.000427	0.0024	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Estradiol—osteoporosis	0.000427	0.0024	CcSEcCtD
Fludrocortisone—Vertigo—Estropipate—osteoporosis	0.000423	0.00238	CcSEcCtD
Fludrocortisone—NR3C1—Endoderm Differentiation—PTHLH—osteoporosis	0.000419	0.00983	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—NFATC1—osteoporosis	0.000417	0.00979	CbGpPWpGaD
Fludrocortisone—Vertigo—Alendronate—osteoporosis	0.000416	0.00234	CcSEcCtD
Fludrocortisone—Vertigo—Raloxifene—osteoporosis	0.00041	0.0023	CcSEcCtD
Fludrocortisone—Haemoglobin—Pamidronate—osteoporosis	0.000408	0.0023	CcSEcCtD
Fludrocortisone—Affect lability—Estradiol—osteoporosis	0.000407	0.00229	CcSEcCtD
Fludrocortisone—Haemorrhage—Pamidronate—osteoporosis	0.000406	0.00228	CcSEcCtD
Fludrocortisone—Vertigo—Ibandronate—osteoporosis	0.000405	0.00228	CcSEcCtD
Fludrocortisone—Methyltestosterone—SHBG—osteoporosis	0.000405	0.0941	CrCbGaD
Fludrocortisone—Musculoskeletal discomfort—Etidronic acid—osteoporosis	0.000404	0.00227	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Conjugated Estrogens—osteoporosis	0.000403	0.00226	CcSEcCtD
Fludrocortisone—Myalgia—Estropipate—osteoporosis	0.000401	0.00225	CcSEcCtD
Fludrocortisone—AR—FOXA1 transcription factor network—ESR1—osteoporosis	0.0004	0.00939	CbGpPWpGaD
Fludrocortisone—Myalgia—Alendronate—osteoporosis	0.000395	0.00222	CcSEcCtD
Fludrocortisone—Mood swings—Estradiol—osteoporosis	0.000391	0.0022	CcSEcCtD
Fludrocortisone—Hypertension—Ibandronate—osteoporosis	0.00039	0.00219	CcSEcCtD
Fludrocortisone—Myalgia—Raloxifene—osteoporosis	0.000388	0.00218	CcSEcCtD
Fludrocortisone—Myalgia—Ibandronate—osteoporosis	0.000384	0.00216	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Estropipate—osteoporosis	0.000384	0.00216	CcSEcCtD
Fludrocortisone—Oedema—Estropipate—osteoporosis	0.000384	0.00216	CcSEcCtD
Fludrocortisone—Convulsion—Calcitriol—osteoporosis	0.000383	0.00215	CcSEcCtD
Fludrocortisone—Infection—Estropipate—osteoporosis	0.000382	0.00215	CcSEcCtD
Fludrocortisone—Hypertension—Calcitriol—osteoporosis	0.000381	0.00214	CcSEcCtD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—BGLAP—osteoporosis	0.00038	0.00892	CbGpPWpGaD
Fludrocortisone—Myalgia—Calcitriol—osteoporosis	0.000376	0.00211	CcSEcCtD
Fludrocortisone—Infection—Alendronate—osteoporosis	0.000376	0.00211	CcSEcCtD
Fludrocortisone—Infection—Raloxifene—osteoporosis	0.00037	0.00208	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Ibandronate—osteoporosis	0.000368	0.00207	CcSEcCtD
Fludrocortisone—Infection—Ibandronate—osteoporosis	0.000366	0.00206	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Calcitriol—osteoporosis	0.00036	0.00203	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Raloxifene—osteoporosis	0.00036	0.00202	CcSEcCtD
Fludrocortisone—Abdominal distension—Estradiol—osteoporosis	0.00036	0.00202	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Ibandronate—osteoporosis	0.000356	0.002	CcSEcCtD
Fludrocortisone—AR—Nuclear Receptor transcription pathway—ESR1—osteoporosis	0.000355	0.00835	CbGpPWpGaD
Fludrocortisone—Erythema—Pamidronate—osteoporosis	0.000353	0.00199	CcSEcCtD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—VDR—osteoporosis	0.000353	0.00829	CbGpPWpGaD
Fludrocortisone—Urticaria—Etidronic acid—osteoporosis	0.000353	0.00198	CcSEcCtD
Fludrocortisone—Pancreatitis—Estradiol—osteoporosis	0.00035	0.00197	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Estropipate—osteoporosis	0.00035	0.00197	CcSEcCtD
Fludrocortisone—Sweating increased—Estradiol—osteoporosis	0.000348	0.00196	CcSEcCtD
Fludrocortisone—Insomnia—Estropipate—osteoporosis	0.000347	0.00195	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—GAPDH—osteoporosis	0.000346	0.00812	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—RAP1A—osteoporosis	0.000346	0.00811	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Alendronate—osteoporosis	0.000345	0.00194	CcSEcCtD
Fludrocortisone—NR3C1—Signaling events mediated by HDAC Class II—ESR1—osteoporosis	0.000341	0.00801	CbGpPWpGaD
Fludrocortisone—NR3C1—Nuclear Receptors—ESR1—osteoporosis	0.000341	0.00801	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Raloxifene—osteoporosis	0.000339	0.00191	CcSEcCtD
Fludrocortisone—Fluoxymesterone—ESR1—osteoporosis	0.000339	0.0787	CrCbGaD
Fludrocortisone—Insomnia—Raloxifene—osteoporosis	0.000336	0.00189	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.000336	0.00189	CcSEcCtD
Fludrocortisone—Vertigo—Risedronate—osteoporosis	0.000334	0.00188	CcSEcCtD
Fludrocortisone—Insomnia—Ibandronate—osteoporosis	0.000333	0.00187	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.000328	0.00185	CcSEcCtD
Fludrocortisone—Hypersensitivity—Etidronic acid—osteoporosis	0.000327	0.00184	CcSEcCtD
Fludrocortisone—Insomnia—Calcitriol—osteoporosis	0.000326	0.00183	CcSEcCtD
Fludrocortisone—Erythema—Zoledronate—osteoporosis	0.000323	0.00182	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Estradiol—osteoporosis	0.000322	0.00181	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—VDR—osteoporosis	0.000321	0.00754	CbGpPWpGaD
Fludrocortisone—Hypertension—Risedronate—osteoporosis	0.000321	0.00181	CcSEcCtD
Fludrocortisone—Myalgia—Risedronate—osteoporosis	0.000317	0.00178	CcSEcCtD
Fludrocortisone—Oedema—Ethinyl Estradiol—osteoporosis	0.000311	0.00175	CcSEcCtD
Fludrocortisone—Erythema—Conjugated Estrogens—osteoporosis	0.000311	0.00175	CcSEcCtD
Fludrocortisone—Infection—Ethinyl Estradiol—osteoporosis	0.000309	0.00174	CcSEcCtD
Fludrocortisone—Convulsion—Pamidronate—osteoporosis	0.000306	0.00172	CcSEcCtD
Fludrocortisone—Hypertension—Pamidronate—osteoporosis	0.000305	0.00172	CcSEcCtD
Fludrocortisone—Urticaria—Estropipate—osteoporosis	0.000305	0.00172	CcSEcCtD
Fludrocortisone—Hydrocortisone—SHBG—osteoporosis	0.000305	0.0708	CrCbGaD
Fludrocortisone—Infection—Risedronate—osteoporosis	0.000302	0.0017	CcSEcCtD
Fludrocortisone—Myalgia—Pamidronate—osteoporosis	0.000301	0.00169	CcSEcCtD
Fludrocortisone—Urticaria—Alendronate—osteoporosis	0.0003	0.00169	CcSEcCtD
Fludrocortisone—Methyltestosterone—CYP19A1—osteoporosis	0.000297	0.069	CrCbGaD
Fludrocortisone—Urticaria—Ibandronate—osteoporosis	0.000293	0.00165	CcSEcCtD
Fludrocortisone—Medroxyprogesterone Acetate—ESR1—osteoporosis	0.000291	0.0675	CrCbGaD
Fludrocortisone—Vertigo—Zoledronate—osteoporosis	0.00029	0.00163	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Pamidronate—osteoporosis	0.000289	0.00162	CcSEcCtD
Fludrocortisone—Oedema—Pamidronate—osteoporosis	0.000289	0.00162	CcSEcCtD
Fludrocortisone—Haemoglobin—Estradiol—osteoporosis	0.000287	0.00162	CcSEcCtD
Fludrocortisone—Betamethasone—CYP19A1—osteoporosis	0.000287	0.0666	CrCbGaD
Fludrocortisone—Infection—Pamidronate—osteoporosis	0.000287	0.00161	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	0.000286	0.00672	CbGpPWpGaD
Fludrocortisone—Urticaria—Calcitriol—osteoporosis	0.000286	0.00161	CcSEcCtD
Fludrocortisone—Haemorrhage—Estradiol—osteoporosis	0.000286	0.00161	CcSEcCtD
Fludrocortisone—Hypersensitivity—Estropipate—osteoporosis	0.000283	0.00159	CcSEcCtD
Fludrocortisone—Convulsion—Zoledronate—osteoporosis	0.00028	0.00157	CcSEcCtD
Fludrocortisone—Vertigo—Conjugated Estrogens—osteoporosis	0.000279	0.00157	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Pamidronate—osteoporosis	0.000279	0.00157	CcSEcCtD
Fludrocortisone—Hypertension—Zoledronate—osteoporosis	0.000279	0.00157	CcSEcCtD
Fludrocortisone—Hypersensitivity—Alendronate—osteoporosis	0.000279	0.00157	CcSEcCtD
Fludrocortisone—Headache—Etidronic acid—osteoporosis	0.000278	0.00156	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000277	0.00155	CcSEcCtD
Fludrocortisone—NR3C1—Adipogenesis—WNT1—osteoporosis	0.000276	0.00647	CbGpPWpGaD
Fludrocortisone—Asthenia—Estropipate—osteoporosis	0.000276	0.00155	CcSEcCtD
Fludrocortisone—Myalgia—Zoledronate—osteoporosis	0.000275	0.00155	CcSEcCtD
Fludrocortisone—Insomnia—Risedronate—osteoporosis	0.000274	0.00154	CcSEcCtD
Fludrocortisone—NR3C2—Gene Expression—U2AF1—osteoporosis	0.000274	0.00644	CbGpPWpGaD
Fludrocortisone—Asthenia—Alendronate—osteoporosis	0.000271	0.00153	CcSEcCtD
Fludrocortisone—Hypersensitivity—Ibandronate—osteoporosis	0.000271	0.00153	CcSEcCtD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—ESR1—osteoporosis	0.00027	0.00633	CbGpPWpGaD
Fludrocortisone—Convulsion—Conjugated Estrogens—osteoporosis	0.000269	0.00151	CcSEcCtD
Fludrocortisone—Hypersensitivity—Calcitriol—osteoporosis	0.000266	0.00149	CcSEcCtD
Fludrocortisone—Myalgia—Conjugated Estrogens—osteoporosis	0.000265	0.00149	CcSEcCtD
Fludrocortisone—Asthenia—Ibandronate—osteoporosis	0.000264	0.00149	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Zoledronate—osteoporosis	0.000264	0.00148	CcSEcCtD
Fludrocortisone—Oedema—Zoledronate—osteoporosis	0.000264	0.00148	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000263	0.00148	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—GAPDH—osteoporosis	0.000262	0.00616	CbGpPWpGaD
Fludrocortisone—Infection—Zoledronate—osteoporosis	0.000262	0.00147	CcSEcCtD
Fludrocortisone—Insomnia—Pamidronate—osteoporosis	0.000261	0.00147	CcSEcCtD
Fludrocortisone—Asthenia—Calcitriol—osteoporosis	0.000259	0.00145	CcSEcCtD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—TNF—osteoporosis	0.000256	0.00601	CbGpPWpGaD
Fludrocortisone—Hyperhidrosis—Zoledronate—osteoporosis	0.000255	0.00143	CcSEcCtD
Fludrocortisone—Oedema—Conjugated Estrogens—osteoporosis	0.000254	0.00143	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000254	0.00143	CcSEcCtD
Fludrocortisone—Infection—Conjugated Estrogens—osteoporosis	0.000252	0.00142	CcSEcCtD
Fludrocortisone—NR3C1—Adipogenesis—BMP2—osteoporosis	0.000249	0.00585	CbGpPWpGaD
Fludrocortisone—Erythema—Estradiol—osteoporosis	0.000249	0.0014	CcSEcCtD
Fludrocortisone—Progesterone—SHBG—osteoporosis	0.000248	0.0577	CrCbGaD
Fludrocortisone—Urticaria—Ethinyl Estradiol—osteoporosis	0.000247	0.00139	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—osteoporosis	0.000246	0.00576	CbGpPWpGaD
Fludrocortisone—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000245	0.00138	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—osteoporosis	0.000244	0.00572	CbGpPWpGaD
Fludrocortisone—Urticaria—Risedronate—osteoporosis	0.000241	0.00136	CcSEcCtD
Fludrocortisone—Headache—Estropipate—osteoporosis	0.000241	0.00135	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.00024	0.00135	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—ESR2—osteoporosis	0.00024	0.00563	CbGpPWpGaD
Fludrocortisone—Insomnia—Zoledronate—osteoporosis	0.000238	0.00134	CcSEcCtD
Fludrocortisone—Headache—Alendronate—osteoporosis	0.000237	0.00133	CcSEcCtD
Fludrocortisone—Testosterone—SHBG—osteoporosis	0.000235	0.0546	CrCbGaD
Fludrocortisone—Headache—Raloxifene—osteoporosis	0.000233	0.00131	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000231	0.0013	CcSEcCtD
Fludrocortisone—Headache—Ibandronate—osteoporosis	0.000231	0.0013	CcSEcCtD
Fludrocortisone—Insomnia—Conjugated Estrogens—osteoporosis	0.00023	0.00129	CcSEcCtD
Fludrocortisone—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000229	0.00129	CcSEcCtD
Fludrocortisone—Headache—Calcitriol—osteoporosis	0.000226	0.00127	CcSEcCtD
Fludrocortisone—Hypersensitivity—Risedronate—osteoporosis	0.000224	0.00126	CcSEcCtD
Fludrocortisone—Vertigo—Estradiol—osteoporosis	0.000224	0.00126	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CYP19A1—osteoporosis	0.000223	0.00524	CbGpPWpGaD
Fludrocortisone—Asthenia—Ethinyl Estradiol—osteoporosis	0.000223	0.00126	CcSEcCtD
Fludrocortisone—NR3C2—Generic Transcription Pathway—ESR2—osteoporosis	0.000218	0.00512	CbGpPWpGaD
Fludrocortisone—Asthenia—Risedronate—osteoporosis	0.000218	0.00122	CcSEcCtD
Fludrocortisone—Hypertension—Estradiol—osteoporosis	0.000215	0.00121	CcSEcCtD
Fludrocortisone—Hypersensitivity—Pamidronate—osteoporosis	0.000213	0.0012	CcSEcCtD
Fludrocortisone—Myalgia—Estradiol—osteoporosis	0.000212	0.00119	CcSEcCtD
Fludrocortisone—Urticaria—Zoledronate—osteoporosis	0.000209	0.00118	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—ESR1—osteoporosis	0.000209	0.00491	CbGpPWpGaD
Fludrocortisone—Asthenia—Pamidronate—osteoporosis	0.000207	0.00116	CcSEcCtD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—IL6—osteoporosis	0.000207	0.00485	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	0.000204	0.00478	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—RPL24—osteoporosis	0.000204	0.00478	CbGpPWpGaD
Fludrocortisone—Anaphylactic shock—Estradiol—osteoporosis	0.000203	0.00114	CcSEcCtD
Fludrocortisone—Oedema—Estradiol—osteoporosis	0.000203	0.00114	CcSEcCtD
Fludrocortisone—Infection—Estradiol—osteoporosis	0.000202	0.00113	CcSEcCtD
Fludrocortisone—Urticaria—Conjugated Estrogens—osteoporosis	0.000202	0.00113	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Estradiol—osteoporosis	0.000196	0.0011	CcSEcCtD
Fludrocortisone—Headache—Ethinyl Estradiol—osteoporosis	0.000195	0.0011	CcSEcCtD
Fludrocortisone—Hypersensitivity—Zoledronate—osteoporosis	0.000194	0.00109	CcSEcCtD
Fludrocortisone—Headache—Risedronate—osteoporosis	0.00019	0.00107	CcSEcCtD
Fludrocortisone—Asthenia—Zoledronate—osteoporosis	0.000189	0.00106	CcSEcCtD
Fludrocortisone—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000187	0.00105	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—osteoporosis	0.000186	0.00437	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000185	0.00104	CcSEcCtD
Fludrocortisone—Insomnia—Estradiol—osteoporosis	0.000184	0.00103	CcSEcCtD
Fludrocortisone—Asthenia—Conjugated Estrogens—osteoporosis	0.000182	0.00102	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—ESR2—osteoporosis	0.000182	0.00427	CbGpPWpGaD
Fludrocortisone—Headache—Pamidronate—osteoporosis	0.000181	0.00102	CcSEcCtD
Fludrocortisone—NR3C2—Generic Transcription Pathway—VDR—osteoporosis	0.000173	0.00407	CbGpPWpGaD
Fludrocortisone—Testosterone—CYP19A1—osteoporosis	0.000172	0.04	CrCbGaD
Fludrocortisone—Progesterone—ESR1—osteoporosis	0.000168	0.039	CrCbGaD
Fludrocortisone—Dexamethasone—CYP19A1—osteoporosis	0.000167	0.0387	CrCbGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—POMC—osteoporosis	0.000166	0.0039	CbGpPWpGaD
Fludrocortisone—Headache—Zoledronate—osteoporosis	0.000165	0.000928	CcSEcCtD
Fludrocortisone—Urticaria—Estradiol—osteoporosis	0.000161	0.000907	CcSEcCtD
Fludrocortisone—Headache—Conjugated Estrogens—osteoporosis	0.000159	0.000894	CcSEcCtD
Fludrocortisone—Hypersensitivity—Estradiol—osteoporosis	0.00015	0.000841	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—ESR1—osteoporosis	0.000149	0.0035	CbGpPWpGaD
Fludrocortisone—Asthenia—Estradiol—osteoporosis	0.000146	0.000819	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—IRS1—osteoporosis	0.000139	0.00327	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—IRS2—osteoporosis	0.000137	0.00321	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—LEP—osteoporosis	0.000134	0.00314	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—ESR1—osteoporosis	0.000132	0.00311	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—osteoporosis	0.000129	0.00303	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—osteoporosis	0.000128	0.003	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—IL6R—osteoporosis	0.000128	0.00299	CbGpPWpGaD
Fludrocortisone—Headache—Estradiol—osteoporosis	0.000127	0.000715	CcSEcCtD
Fludrocortisone—AR—Gene Expression—U2AF1—osteoporosis	0.000127	0.00299	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	0.000124	0.0029	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—IRS1—osteoporosis	0.000119	0.0028	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—PSMA2—osteoporosis	0.000118	0.00276	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—PSMA5—osteoporosis	0.000118	0.00276	CbGpPWpGaD
Fludrocortisone—NR3C1—Endoderm Differentiation—TGFB1—osteoporosis	0.000111	0.00261	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—IGF1—osteoporosis	0.00011	0.00259	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—MYC—osteoporosis	0.000109	0.00256	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—TGFB1—osteoporosis	0.000109	0.00255	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	0.000107	0.00251	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—ESR2—osteoporosis	0.000105	0.00247	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—ESR2—osteoporosis	0.000101	0.00238	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—IL1B—osteoporosis	9.7e-05	0.00228	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—osteoporosis	9.69e-05	0.00227	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—IL6R—osteoporosis	9.68e-05	0.00227	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—U2AF1—osteoporosis	9.65e-05	0.00227	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—RPL24—osteoporosis	9.45e-05	0.00222	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—VDR—osteoporosis	8.34e-05	0.00196	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—IL6—osteoporosis	8.19e-05	0.00192	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—VDR—osteoporosis	8.04e-05	0.00189	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—MYC—osteoporosis	7.76e-05	0.00182	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—ESR2—osteoporosis	7.68e-05	0.0018	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—IL1B—osteoporosis	7.36e-05	0.00173	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IL6—osteoporosis	7.21e-05	0.00169	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—RPL24—osteoporosis	7.17e-05	0.00168	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—TNF—osteoporosis	7.04e-05	0.00165	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—MYC—osteoporosis	6.88e-05	0.00162	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—TGFB1—osteoporosis	6.62e-05	0.00155	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	6.43e-05	0.00151	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	6.41e-05	0.00151	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—ESR1—osteoporosis	6.37e-05	0.0015	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—TNF—osteoporosis	6.18e-05	0.00145	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—ESR1—osteoporosis	6.14e-05	0.00144	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—VDR—osteoporosis	6.1e-05	0.00143	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	5.99e-05	0.00141	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—IL6—osteoporosis	5.68e-05	0.00133	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—PSMA5—osteoporosis	5.46e-05	0.00128	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—PSMA2—osteoporosis	5.46e-05	0.00128	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—TNF—osteoporosis	5.34e-05	0.00125	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—IL6—osteoporosis	4.99e-05	0.00117	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—ESR2—osteoporosis	4.87e-05	0.00114	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—ESR1—osteoporosis	4.66e-05	0.00109	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—IL6—osteoporosis	4.31e-05	0.00101	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—PSMA2—osteoporosis	4.14e-05	0.000972	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—PSMA5—osteoporosis	4.14e-05	0.000972	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—VDR—osteoporosis	3.87e-05	0.000908	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—ESR2—osteoporosis	3.7e-05	0.000868	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—MYC—osteoporosis	3.31e-05	0.000778	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—MYC—osteoporosis	3.19e-05	0.00075	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—ESR1—osteoporosis	2.96e-05	0.000694	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—VDR—osteoporosis	2.94e-05	0.000689	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—MYC—osteoporosis	2.42e-05	0.000569	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—ESR1—osteoporosis	2.24e-05	0.000527	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—MYC—osteoporosis	1.54e-05	0.000361	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—MYC—osteoporosis	1.17e-05	0.000274	CbGpPWpGaD
